Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE studyJohan Hansson, Axel Hauschild, Brigitte Dréno et al.|European Journal of Dermatology|2018Cited by 26
Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAFV600 mutation–positive melanomaBrigitte Dréno, Antoni Ribas, Isabelle Rooney et al.|British Journal of Cancer|2018Cited by 24
Quality-of-life (QOL) assessment in patients (pts) with metastatic melanoma receiving vemurafenib (V) and cobimetinib (C).Brigitte Dréno, Antoni Ribas, Claus Garbe et al.|Journal of Clinical Oncology|2015Cited by 7
3342 Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma (BCC) treated with vismodegib in the STEVIE studyJohan Hansson, Axel Hauschild, Caroline Dutriaux et al.|European Journal of Cancer|2015Cited by 2